MANUFACTURERS LIFE INSURANCE COMPANY, THE - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$3,644,038
+19.4%
229,618
+42.0%
0.00%0.0%
Q2 2023$3,051,260
+852.9%
161,699
+93.9%
0.00%
Q1 2023$320,214
-22.6%
83,3890.0%0.00%
Q4 2022$413,609
+3.2%
83,389
-0.5%
0.00%
Q3 2022$400,731
+3.8%
83,835
-2.3%
0.00%
Q2 2022$386,096
-5.0%
85,799
+0.5%
0.00%
Q1 2022$406,337
-46.9%
85,365
-17.2%
0.00%
Q4 2021$765,000
+29.7%
103,055
-1.0%
0.00%
Q3 2021$590,000
-19.5%
104,095
-6.4%
0.00%
-100.0%
Q2 2021$733,000
-16.5%
111,206
+2.6%
0.00%0.0%
Q1 2021$878,000
+23.5%
108,361
-1.7%
0.00%0.0%
Q4 2020$711,000
+91.6%
110,258
+7.1%
0.00%
Q3 2020$371,000
-17.6%
102,9570.0%0.00%
Q2 2020$450,000
+26.4%
102,957
-1.3%
0.00%
Q1 2020$356,000
-21.4%
104,351
+17.6%
0.00%
Q4 2019$453,000
+77.0%
88,752
-5.7%
0.00%
Q3 2019$256,000
+21.3%
94,086
-3.1%
0.00%
Q2 2019$211,000
-19.8%
97,123
-0.1%
0.00%
Q1 2019$263,000
-38.3%
97,205
+9.6%
0.00%
-100.0%
Q4 2018$426,000
-52.0%
88,678
-5.4%
0.00%0.0%
Q3 2018$887,000
-4.2%
93,728
-1.5%
0.00%0.0%
Q2 2018$926,000
+17.4%
95,177
+27.0%
0.00%0.0%
Q1 2018$789,000
+59.4%
74,960
-2.8%
0.00%0.0%
Q4 2017$495,000
-1.0%
77,143
+17.9%
0.00%0.0%
Q3 2017$500,000
+5.0%
65,408
-2.3%
0.00%0.0%
Q2 2017$476,000
+70.6%
66,935
-7.0%
0.00%
Q1 2017$279,000
+103.6%
71,965
+7.0%
0.00%
Q4 2016$137,000
-14.4%
67,260
+12.7%
0.00%
Q3 2016$160,000
-14.9%
59,677
-2.1%
0.00%
Q2 2016$188,000
-60.3%
60,936
+6.3%
0.00%
Q1 2016$474,000
-38.3%
57,308
+1.3%
0.00%
-100.0%
Q4 2015$768,000
+42.8%
56,575
+1.1%
0.00%0.0%
Q3 2015$538,000
-31.6%
55,971
+2.4%
0.00%0.0%
Q2 2015$786,000
+54.4%
54,638
-3.9%
0.00%0.0%
Q1 2015$509,000
+51.9%
56,849
+3.4%
0.00%
Q4 2014$335,000
-43.0%
54,990
-0.9%
0.00%
-100.0%
Q3 2014$588,000
-10.8%
55,514
-0.1%
0.00%0.0%
Q2 2014$659,000
-31.3%
55,576
-13.5%
0.00%
-50.0%
Q1 2014$959,000
+1.6%
64,273
-0.1%
0.00%
+100.0%
Q4 2013$944,000
-13.6%
64,367
+0.3%
0.00%
-50.0%
Q3 2013$1,092,000
-0.5%
64,188
-2.9%
0.00%0.0%
Q2 2013$1,097,00066,1250.00%
Other shareholders
IMMUNOGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders